MUCOCURE-AFM is indicated for allergic asthma and bronchial disorders. It helps reduce airway inflammation and mucus secretion. The formulation improves breathing comfort and lung function. MUCOCURE-AFM is effective in chronic bronchitis and allergic rhinitis. Suitable for long-term respiratory management.
Mucocure-AFM is a triple-action formulation designed to provide effective relief from allergic asthma, bronchial inflammation, and mucus obstruction, ensuring improved respiratory comfort and airflow.
Comprehensive respiratory support with anti-allergic and anti-inflammatory action
Improves airway patency and breathing
Reduces mucus viscosity and bronchial obstruction
Controls allergic inflammation in airways and nasal passages
Non-sedating anti-allergic action
Enhances overall respiratory function in asthma patients
Acebrophylline: Acts as an airway mucoregulator, thins and loosens mucus, and exhibits bronchodilatory and anti-inflammatory effects.
Fexofenadine: Selective H1 antihistamine that reduces allergic symptoms without sedation and controls sneezing, nasal congestion, and rhinorrhea.
Montelukast: Leukotriene receptor antagonist that reduces airway inflammation and improves bronchial responsiveness in asthma.
Mucocure-AFM delivers triple-pathway respiratory protection by combining mucolytic, anti-allergic, and anti-inflammatory actions—making it a reliable choice for long-term management of allergic asthma and airway diseases.